PUBLIC CONTRACT · 2021
4180325/2021 - Aq. Central B712 - Bictegravir 50MG + emtricitabina 200MG + tenofovir alaf 25MG comp reves
- Contract value
- €43,711.50
- Signed on
- 29 July 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 8710127PUBLISHED SUBJECT
4180325/2021 - AQ. CENTRAL B712 - BICTEGRAVIR 50MG + EMTRICITABINA 200MG + TENOFOVIR ALAF 25MG COMP REVES
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GILEAD SCIENCES, LDA · Tax ID 503604704
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €43,711.50
- Procedure base price
- €43,711.50
- Total effective price
- €43,711.50
- Publication date
- 14 January 2022
- Award date
- 29 July 2021
- Signing date
- 29 July 2021
- Performance period
- 20 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2019/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5736622
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.